Abstract
Sulindac (Clinoril; Frosst-MSD), a non-steroidal anti-inflammatory drug was compared with aspirin in a randomized double-blind cross-over controlled study in 30 patients with juvenile chronic arthritis. Sulindac was found to be safe and effective. Although it has the advantage of a twice-a-day dose regimen, both patient and doctor may prefer to be guided by pain relief and cost.
Publication types
-
Clinical Trial
-
Comparative Study
-
Randomized Controlled Trial
MeSH terms
-
Adolescent
-
Adult
-
Arthritis, Juvenile / drug therapy*
-
Aspirin / adverse effects
-
Aspirin / therapeutic use*
-
Child
-
Child, Preschool
-
Chronic Disease
-
Clinical Trials as Topic
-
Double-Blind Method
-
Drug Evaluation
-
Female
-
Humans
-
Indenes / therapeutic use*
-
Male
-
Random Allocation
-
Sulindac / adverse effects
-
Sulindac / therapeutic use*